Clinical Trial Update: Study of Methotrexate Efficacy Versus Cyclosporine in Moderate to Severe Atopic Dermatitis Patients [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 trial comparing methotrexate and cyclosporine in patients with moderate-to-severe atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED